Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings

Authors

Nidhiben Anadani
Megan Hyland
Roberto A. Cruz, The University of Texas Rio Grande ValleyFollow
Robert Lisak
Kathleen Costello
Eugene O. Major
Yasir Jassam
Ethan Meltzer
Thomas C. Varkey
Matthew S. Parsons

Document Type

Conference Proceeding

Publication Date

12-15-2020

Abstract

A 38-year-old woman with MS receiving natalizumab presented to the neurology clinic with the complaint of a new neurologic symptom.

Comments

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 1

Recommended Citation

Anadani, N., Hyland, M., Cruz, R. A., Lisak, R., Costello, K., Major, E. O., Jassam, Y., Meltzer, E., Varkey, T. C., Parsons, M. S., Goodman, A. D., Graves, J. S., Newsome, S., Zamvil, S. S., Frohman, E. M., & Frohman, T. C. (2021). Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology - Neuroimmunology Neuroinflammation, 8(1), e929. https://doi.org/10.1212/NXI.0000000000000929

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Publication Title

Neurology - Neuroimmunology Neuroinflammation

DOI

10.1212/NXI.0000000000000929

Academic Level

faculty

Mentor/PI Department

Neurology